~%2FDocuments%2FRStudio_Projects%2Fpharma-wg-oversight-committee%2FMinutes%2FPOC_02-16-22_Minutes.md="FC0516CB"
~%2FDocuments%2FRStudio_Projects%2Fpharma-wg-oversight-committee%2FMinutes%2FPOC_12-15-21_Minutes.Rmd="DBD3ECEE"
~%2FDocuments%2FRStudio_Projects%2Fpharma-wg-oversight-committee%2FMinutes%2FPOC_Minutes_11-17-2021.Rmd="CF0D2AD7"
~%2FDocuments%2FRStudio_Projects%2Fpharma-wg-oversight-committee%2FMinutes%2FPOC_Minutes_4-27-21.Rmd="DE5F4E6B"
~%2FDocuments%2FRStudio_Projects%2Fpharma-wg-oversight-committee%2FMinutes%2FPOC_Minutes_5-19-21.Rmd="7BC6D8C8"
~%2FDocuments%2FRStudio_Projects%2Fpharma-wg-oversight-committee%2FMinutes%2FPOC_Minutes_8-16-21.Rmd="6630DBB4"
~%2FDocuments%2FRStudio_Projects%2Fpharma-wg-oversight-committee%2FMinutes%2FPOC_Minutes_9-15-21.Rmd="6EEBCF03"
~%2FDocuments%2FRStudio_Projects%2Fpharma-wg-oversight-committee%2FPOC_Minutes_4-27-21.Rmd="0D463685"
